LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, will be presenting at the Bear Stearns 3rd Annual Boston Biotech Confab Conference, at the Boston Marriott Copley Place on Thursday, June 7th at 1:40 p.m. (ET).
